Can Lithium Cause Sinus Arrhythmia?
Yes, lithium can cause sinus arrhythmias, most commonly sinus bradycardia and sinus node dysfunction, occurring at both therapeutic and toxic levels, though the risk increases substantially with elevated serum concentrations.
Cardiac Arrhythmias Associated with Lithium
Lithium causes a spectrum of cardiac rhythm disturbances, with sinus node dysfunction being the most clinically significant:
Common Arrhythmias
- Sinus bradycardia is the most frequently reported arrhythmia, occurring even at therapeutic lithium levels 1, 2, 3
- Sinus node dysfunction with variable degrees of sinoatrial block has been documented in 54.39% of reported cases 4
- Sinus arrest occurs in approximately 29.82% of cases with lithium-induced cardiac toxicity 4
- T-wave changes (flattening, isoelectricity, or inversion) are the most common ECG finding overall 1, 3
Mechanism of Arrhythmia
The FDA label explicitly lists "cardiac arrhythmia" and "sinus node dysfunction with severe bradycardia (which may result in syncope)" as adverse cardiovascular reactions 1. The mechanism involves lithium's potent blockade of cardiac sodium channels, which are critical for pacemaker activity in the sinoatrial node 5. This sodium channel blockade directly impairs the automaticity of the sinus node, leading to bradyarrhythmias.
Risk Stratification by Serum Lithium Level
Therapeutic Levels (0.6-1.2 mEq/L)
- Sinus node dysfunction can occur even within therapeutic range 6, 5, 7
- In systematic review, 21.1% of patients with lithium-induced sinus node dysfunction had normotherapeutic levels 4
- 19.3% had subtherapeutic levels, indicating risk exists across the concentration spectrum 4
Toxic Levels (>1.5 mEq/L)
- Risk substantially increases above 1.5 mEq/L 1
- 61.4% of patients with sinus node dysfunction presented with supratherapeutic lithium levels 4
- European Heart Journal guidelines note that bradycardia, T-wave changes, and AV-block have been described with lithium, though reports regarding QT prolongation are divergent 8
Clinical Severity and Outcomes
Acute Management Requirements
- 21.1% required inotropic or vasopressor support for hemodynamic compromise 4, 9
- 17.5% required temporary cardiac pacing during acute presentation 4
- 12.3% required permanent pacemaker implantation for persistent sinus node dysfunction 4, 7
Prognosis
- 87.7% of patients recovered completely after lithium discontinuation or level normalization 4
- Most cases are reversible upon discontinuation of lithium 2, 6
- 3.5% developed persistent sinus node dysfunction requiring permanent pacing 4
- 3.5% mortality rate directly attributable to acute lithium toxicity 4
Clinical Pitfalls and Monitoring
Key Caveats
- Duration-dependent effects: Electrical changes depend on both duration of treatment and serum lithium level 3
- Drug interactions: Concomitant use with anti-arrhythmic drugs requires caution 8
- Electrolyte disturbances: Lithium decreases sodium reabsorption, potentially leading to sodium depletion that exacerbates cardiac effects 1
Essential Workup for Lithium-Associated Bradycardia
Before attributing bradycardia to lithium, exclude:
- Calcium abnormalities
- Thyroid dysfunction (lithium commonly causes hypothyroidism) 1, 6
- Medication interactions (particularly with diuretics, ACE inhibitors, NSAIDs) 1
- Underlying structural heart disease 6
Novel Treatment Approach
Oral theophylline has been successfully used to correct lithium-induced sinus node dysfunction, providing temporary chronotropic support while lithium levels normalize, potentially avoiding more invasive interventions like temporary pacing or hemodialysis 4. This represents a preferable first-line approach when transient dysfunction is expected to resolve with lithium elimination.
ECG Monitoring Recommendations
While no standardized ECG guidelines exist for lithium therapy 3, the evidence supports:
- Baseline ECG before initiating lithium therapy, particularly in patients with cardiac risk factors
- Serial monitoring during dose adjustments or when daily doses are high
- Immediate ECG if symptoms of bradycardia develop (dizziness, syncope, fatigue) 3